National Community Anti-Drug Coalition Institute (NCI)
ID: 357447Type: Forecasted
Overview

Buyer

Office of National Drug Control Policy (ONDCP)

Award Range

$0 - $3M

Eligible Applicants

Nonprofits Without 501(c)(3) Status

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357447
Timeline
    Description

    The Office of National Drug Control Policy (ONDCP) is forecasting a grant opportunity titled the National Community Anti-Drug Coalition Institute (NCI), aimed at enhancing the capacity of community coalitions to implement evidence-based substance use prevention interventions. The primary objectives of this grant are to increase the effectiveness of community coalitions across the United States and to strengthen the technical assistance and training provided to these coalitions, particularly during the critical adolescent years when substance use initiation is most prevalent. With an estimated total program funding of $2.5 million and a single award anticipated, eligible applicants include national nonprofit organizations with expertise in community anti-drug coalitions. Interested parties should note that the estimated synopsis post date is December 9, 2024, with a closing date for applications on February 7, 2025, and the expected award date is March 10, 2025. For further inquiries, applicants can contact Helen Hernandez, Assistant Director for Drug Free Communities, at Helen_Hernandez@ondcp.eop.gov or by phone at 202-395-6665.

    Point(s) of Contact
    Helen Hernandez Assistant Director for Drug Free Communities
    (202) 395-6665
    Helen_Hernandez@ondcp.eop.gov
    Files
    No associated files provided.
    Similar Opportunities
    Drug-Free Communities (DFC) Support Program - NEW (Year 1)
    Active
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen community coalitions focused on preventing youth substance use, with the overarching goals of fostering collaboration among various stakeholders and reducing substance abuse among youth and adults. Eligible applicants include nonprofit organizations with 501(c)(3) status, community-based coalitions, and other entities that support these initiatives, with a total estimated funding of $62.5 million and an award ceiling of $125,000 per grant. Interested parties should note that applications must be submitted electronically by March 25, 2025, and can direct inquiries to Brandis Belser at dfcnofo@cdc.gov.
    Drug-Free Communities (DFC) Support Program - Competing Continuation (Year 6)
    Active
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC), through the National Center for Injury Prevention and Control (NCIPC), is forecasting the availability of grants under the Drug-Free Communities (DFC) Support Program for Fiscal Year 2025. This program aims to establish and strengthen collaborations among community coalitions to prevent and reduce substance use among youth, specifically targeting individuals aged 18 and younger. Eligible applicants include community-based coalitions that have previously received DFC funding and are either resuming after a lapse or entering a second five-year funding cycle. The total estimated funding for this opportunity is $12.5 million, with individual awards ranging from $0 to $125,000, and approximately 100 awards expected to be made. Interested parties should note that applications must be submitted electronically by March 31, 2025, with an anticipated award date of August 29, 2025. For further inquiries, applicants can contact Brandis Belser at dfcnofo@cdc.gov.
    Youth Coalitions for Drug Demand Reduction
    Active
    Bureau of International Narcotics-Law Enforcement
    The Bureau of International Narcotics and Law Enforcement Affairs (INL) has announced a funding opportunity titled "Youth Coalitions for Drug Demand Reduction," aimed at engaging youth in drug demand reduction interventions in Peru. The program seeks proposals to establish at least ten youth coalitions across Peru's coastal, Andean, and Amazonian regions, targeting youth aged 12-24 and addressing the rising youth drug use identified by Peru's National Commission for Development and Life without Drugs (DEVIDA). This initiative is crucial for promoting mental health and drug prevention strategies in underserved communities, with a total funding amount of $700,000 available for a project implementation period of 36 months starting in March 2025. Interested applicants must submit their proposals by January 10, 2025, and can reach out to the grantor at parsonsdm@state.gov for further information.
    Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity titled "NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity," which aims to support research initiatives that address the intersection of substance use and racial equity. This grant program, utilizing the DP1 activity code, is designed to foster meaningful collaborations and innovative projects in this critical area of health research. With an estimated total program funding of $3.5 million and an award ceiling of $700,000, the anticipated application period will open in Fall 2025, following the expected publication of the notice of funding opportunity in Spring 2025. Interested applicants should prepare to submit their proposals by the estimated closing date of October 14, 2025, with awards expected to be made by July 1, 2026.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications for diverse preclinical and clinical projects that can expedite the FDA approval process for new treatments, addressing the significant public health need for effective therapies for conditions such as cocaine, methamphetamine, and cannabis use disorders. The program will provide cooperative agreements for projects lasting up to three years, with annual budgets capped at $5 million, and applications are accepted on a rolling basis with specific due dates for scientific merit review established throughout 2023 and 2024. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-22-202.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for research aimed at accelerating the pace of substance use research using existing data, specifically under the R01 grant mechanism. This initiative seeks to promote innovative research projects that leverage existing datasets to enhance understanding and treatment of substance use disorders, with the goal of fostering meaningful collaborations among researchers. The estimated total program funding is $2 million, with approximately three awards expected to be made, and the anticipated application due date is in Spring 2025, following the publication of the Notice of Funding Opportunity in Fall 2024. For further details, potential applicants should prepare to submit their proposals by the estimated close date of June 17, 2025, with awards expected to be announced by April 1, 2026.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis," aimed at supporting research that translates findings into practical solutions for addressing the overdose crisis. This initiative encourages applications from a diverse range of organizations, including educational institutions and nonprofits, with a focus on developing stigma-free, patient-centered systems for addiction recovery and improving the quality of addiction treatment services. The NIH plans to commit approximately $10 million to fund grants, with an expected award ceiling of $750,000 for up to 12 awards, and applications will be accepted starting February 20, 2025, with a closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-077.html.
    Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations." This program aims to reduce the onset and progression of substance misuse and related issues by supporting the development and delivery of community-based prevention and mental health promotion services. The funding is particularly important for domestic public or private non-profit entities, including community-based organizations, local governments, and institutions of higher education, as they work to address substance misuse in their communities. The estimated total program funding is approximately $13,408,701, with no cost-sharing or matching requirement, and interested applicants can reach out to Fred Volpe at (240) 276-2593 or via email at fred.volpe@samhsa.hhs.gov for further details. The synopsis is expected to be posted on January 15, 2025, for the fiscal year 2025.